Ergoteles’s Arrowhead Research ARWR Stock Holding History

Ergoteles’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,916	Closed	-$326K	–	1199
2021 Q4	$326K	Buy	+4,916	New	+$338K	0.01%	823
2021 Q3	–	Sell	-27,587	Closed	-$2.29M	–	1191
2021 Q2	$2.29M	Buy	+27,587	New	+$2.05M	0.05%	346
2020 Q4	–	Sell	-5,800	Closed	-$250K	–	665
2020 Q3	$250K	Buy	+5,800	New	+$250K	0.03%	400

Other funds holding ARWR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Ergoteles's ARWR Position: Q1 2022 in Review

Ergoteles sold out of Arrowhead Research (ARWR) in Q1 2022, closing a stake of 4,916 shares — an estimated $326K sold.

Ergoteles first reported a position in ARWR in Q3 2020 and held it in 3 quarters. The position peaked at $2.29M in Q2 2021. 308 funds tracked by Wall St. Rank hold ARWR as of Q1 2022.

Ergoteles reported no remaining Arrowhead Research position as of Q1 2022 after selling out during the quarter.
Ergoteles sold 4,916 Arrowhead Research shares in Q1 2022, an estimated $326K.
Ergoteles first reported a position in Arrowhead Research in Q3 2020 and held it in 3 quarters.
Ergoteles's Arrowhead Research position peaked at $2.29M in Q2 2021.
308 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2022.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.